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Abstract 
 
Birth is an event that exposes the newborn baby to a high concentration of free radicals 
(reactive oxygen species (ROS) / reactive nitrogen species (RNS)), which can contribute 
to several diseases. The balanced equilibrium between ROS / RNS and the antioxidant 
system of the newborn is a key factor in preventing a plethora of diseases. The 
antioxidant system involves endogenous and exogenous molecules, from vitamins (A, 
E, C), to enzymes (glutathione peroxidase, superoxide dismutase), metals (copper (Cu), 
zinc (Zn), and selenium (Se)) and other molecules (coenzyme Q10, melatonin) that can 
act in a synergistic manner to deactivate free radicals. A competent antioxidant system 
of the baby is strongly dependent on the intake of free radical deactivating molecules 
from feeding, either maternal or formula milk, with several studies pointing that breast 
milk has more powerful antioxidant effects on lowering the infant´s oxidative status. An 
improved understanding of the antioxidant molecules, their mechanism of action, and 
the relationships between them, are key factors to comprehend all the potential benefits 
of human breastfeeding in this matter. The purpose of this review is to describe different 
research efforts and methodologies of evaluation of total antioxidant system (TAS) in 
human milk, and to evaluate and summarize the contribution of different antioxidant 
molecules in TAS, with special emphasis in the last 10 years. 
 
Keywords:  
Total antioxidant status, breast milk, free radicals, antioxidative molecules, oxidative 
stress 
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Abbreviations: AAPH or ABAP (2,2´-azobis (2-methyl-propionamidine) 
hydrochloride); ABTS (2,2´-azinobis(3-ethylbenzothiazole-6-sulphonate); CUPRAC 
(cupric ion-reducing antioxidant capacity; DPPH (2,2-diphenyl-1- picrylhydrazyl 
radical-scavenging capacity); FRAP (ferric reducing antioxidant power); ORAC 
(oxygen radical absorbance capacity); RNS (reactive nitrogen species); ROS (reactive 
oxygen species); TAC (total antioxidant capacity); TAS (total antioxidant status); TE 
(Trolox equivalents ); TEAC (Trolox equivalent antioxidant capacity); TRAP (total 
radical trapping antioxidant parameter). 
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Introduction 
 
Breast milk is the most valuable nourishment available to the newborn. It is an easily 
digestible, readily accessible, low cost, natural food, which contains all the nutritional 
elements, fluids and energy required for growth and development of the newborn, 
besides having many other benefits in developmental, psychological, social and 
economic aspects for both baby and mother. 
Breast-feeding is the best nutrition for the majority of infants during their first months 
of life, being recommended in exclusivity for 6 months, and possibly prolonged for up 
to two years of age or beyond along with appropriate complementary foods (WHO- 
World Health Organization). 
Besides, as is widely acknowledged, having a high nutritional value and supporting the 
immune function, breast milk also has important antioxidative properties. Oxidative 
stress results from a balance between the oxidation induced by reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) and the antioxidative defense system, 
composed by endogenous and exogenous (obtained from the diet) molecules. Breastfed 
children acquire a more competent antioxidant defense, and experience less severe 
oxidative stress than formula-fed children (Aycicek et al., 2006). 
The child's exposure to the environment outside the womb is an oxidative challenge, 
and requires an adaptation from a low-oxygen to a high-oxygen environment. This high 
oxygen concentration increases aerobic metabolic pathways and causes toxic effects on 
tissues, pathologic cellular changes and increase in free radical products (Gitto et al., 
2012; Sandal et al, 2013; Mutinati et al., 2014).  
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Material and methods 
 
Web of Science service was used in December 2014 to search and to download research 
papers, using suitable keywords ((antioxidant or antioxidative) and (“human milk” or 
“breast milk” or breastfeeding)). From a total of 222 titles a selection was performed 
excluding abstracts, patents, non-English papers, animal studies and papers that were 
not available. Other research papers not included in this first search were incorporated 
due to their interest and add value to the theme. 
 
Theory 
Free radicals and Antioxidants 
 
Free radicals are highly reactive molecules, originated chiefly from the mitochondrial 
electron transport chain, containing one or more unpaired electrons, which makes these 
species highly reactant, in order to gain or donate electrons from other molecules, in an 
effort to pair their electrons and produce a more stable species (Gitto et al, 2012; 
Alfadda and Sallam, 2012; Mutinati et al., 2014). They are mainly oxygen (ROS) or 
nitrogen (RNS) centered species, such as the peroxyl radical (ROO
•
), the hydroxyl 
radical (HO
•
), nitric oxide (NO), the superoxide radical (O2
•
), hydrogen peroxide 
(H2O2), peroxyl radical (ROO
•
), hypochlorous acid (HClO) and singlet oxygen (
1
O2), 
each of these molecules being a separate entity with its own reaction, reaction kinetics, 
sites of production or degradation, and diffusion characteristics in biological systems. 
Consequently, the biological role of a free radical depends on the molecule involved and 
on the particular physiological environment in which it is being generated (Murphy et 
al., 2011; Power et al., 2013).  
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Deactivation and scavenging of ROS is critical, since these products are implicated in 
the processes of chronic inflammation and carcinogenesis (Zagierski et al., 2012), and 
in disease states such as insulin resistance and diabetes mellitus, atherosclerosis and 
cardiovascular diseases, cancer, and aging (Alfadda and Sallam, 2012; Halliwell, 2012). 
Generally, ROS species can cause damage in proteins or polyunsaturated fatty acids, 
mutations in DNA, oxidation of membrane phospholipids and modification in low 
density lipoproteins (LDL) (López-Alarcón and Denicola, 2013). In newborns and 
infants, oxidative stress has been related to medical conditions such as 
bronchopulmonary dysplasia, retinopathy of prematurity, and necrotizing enterocolitis 
(Mentro, 2004; Vogelsang et al., 2009; Knuppel et al., 2012; Gitto et al, 2013). 
On the other hand, ROS are also linked to various physiological processes and essential 
protective mechanisms: immune defense, antibacterial action, vascular tone, and signal 
transduction (Alfadda and Sallam, 2012; Graves, 2012; Halliwell, 2012). Consequently, 
equilibrium must be achieved between ROS production and antioxidant activity. 
Oxidative stress appears if the excessive free radicals production is not properly 
balanced by an adequate antioxidative system. 
 
An antioxidant molecule can be defined as a molecule that experimentally prevents the 
oxidation of a biological or chemical system, or that has a chemical structure that allows 
a free radical scavenging reaction and/or the chelation of redox-active metals (Fraga et 
al., 2014). The classical mechanism of action of antioxidants can be described by the 
following reaction (López-Alarcón and Denicola, 2013): 
AH + FR• → A• + FRH  
where AH and FR• represent an antioxidant and a free radical, respectively. 
The majority of nutrient-based antioxidants acts by stopping or slowing the oxidative 
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process once it has begun (chain breaking antioxidants). They can do this by reacting 
with a radical before vital biomolecules are damaged (sacrificial antioxidants) or as 
donor antioxidants, in which they are oxidized to products with insufficient reactivity to 
propagate the radical chain reaction (such as vitamin C, E). The physicochemical 
properties of an antioxidant molecule can dictate its action and efficacy in vivo. 
Hydrophilic antioxidants, such as ascorbic acid, scavenge free radicals in the aqueous 
phase. Lipophilic antioxidants, such as vitamins E, quench radical species present in cell 
membranes or lipid bilayers and provide protection against lipid peroxidation of 
polyunsaturated fatty acids (Power et al., 2013). 
 
Determination of total antioxidant capacity in human milk 
 
Determination of the total antioxidant capacity (TAC) (or total antioxidant system 
(TAS)) is one of the most frequently used strategies to evaluate the free radical-
antioxidant balance in biological systems, and a multitude of research papers have 
described the determination of TAC in human milk. Several methods have been 
developed to assess TAC, most of them based on the reaction of an oxidizable substrate 
with an oxidant to obtain a maximum level of oxidation in the presence or absence of 
the “antioxidant sample” in evaluation (Fraga et al., 2014).  
Based on the chemical reactions involved, the assays for measuring TAC can be 
classified in two major groups:  
1-Competitive methods, in which a substrate and an antioxidant compete for peroxyl 
radicals generated by thermal decomposition of 2,2´-azobis (2-methyl-propionamidine) 
hydrochloride (AAPH or ABAP). Included in such methods one can find (López-
Alarcón and Denicola, 2013; Fraga et al., 2014): 
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- ORAC (oxygen radical absorbance capacity): the peroxyl radicals formed react with 
a fluorescent probe to form a nonfluorescent product. In the presence of antioxidant, 
this reaction is inhibited. TAC is determined by a decrease in the rate and amount of 
fluorescent product formed over time.  
- TRAP (total radical trapping antioxidant parameter): based on measuring oxygen 
consumption during a controlled lipid peroxidation reaction. The presence of an 
antioxidant in the test sample interferes with the reaction.  
 
2-Electron transfer methods, that measure the ability of an antioxidant to reduce an 
oxidant, which also is the probe for monitoring the reaction by a change in 
spectrophotometric absorbance, used to quantify the reducing capacity of the 
antioxidant. Examples are (López-Alarcón and Denicola, 2013): 
- TEAC (Trolox equivalent antioxidant capacity): the mechanism is based on 
scavenging of the 2,2´-azinobis(3-ethylbenzothiazole-6-sulphonate (ABTS) radical 
cation . 
- DPPH (2,2-diphenyl-1- picrylhydrazyl radical-scavenging capacity): DPPH is a 
stable free radical, with an unpaired electron at one atom of the nitrogen bridge. The 
DPPH radical has a violet color and is widely used to monitor the radical scavenging 
ability of various antioxidants. 
- FRAP (ferric reducing antioxidant power): measures the ability of an antioxidant to 
reduce a ferric ion complex to a ferrous complex, detected spectrophotometrically. 
- CUPRAC (cupric ion-reducing antioxidant capacity): determines the ability of a 
sample to reduce the neocuproine-cupric complex  
 
The TEAC (ABTS) and DPPH assays are amongst the most used methods to quantify 
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TAC in human milk. Researchers compared the 2 methods and reported a lack of linear 
correlation between the results obtained by both techniques, and that TAC levels 
determined by the ABTS method were significantly higher than those reported in the 
DPPH assay. The reasons pointed for that were the limitation of DPPH assay: lower 
sensitivity, a slower reaction with most antioxidants, DPPH dissolves only in polar 
matrices and human milk contains components whose spectra overlap with DPPH•. 
These limitations question the DPPH assay as suitable for the determination of TAC 
values in human milk (Martysiak-Żurowska and Wenta, 2012). 
Other in vitro methods were described that measure specific ROS and RNS species. 
These tests include superoxide, hydrogen peroxide, hydroxyl, single oxygen and 
peroxynitrite scavenging assays. However, TAS determination may give more precise 
information than the measurement of each component separately, since the decrease in 
one component may be compensated by the increase in another, so that all the 
antioxidant machinery behaves as a self-regulating system (Sandal et al., 2013). 
Nevertheless, in vitro measurement of TAS cannot be straight forwardly related to their 
antioxidant capacity in the in vivo situation, since their bioavailability, distribution, or 
metabolism are not evaluated in these assays.  
Approaches closer to the in vivo situation can be attempted with in vitro studies such as 
the use of cell culture models, as the model of the human intestinal mucosa, Caco-2 
cells. These cells were used to study the antioxidant activity of breast milk after its in 
vitro digestion, mimicking the physiological microenvironment of intestinal mucosa and 
digestion conditions, confirming that human milk reduces the oxidative stress in the 
studied system (Yao et al. 2010).  
 
Colostrum is the first fluid produced by the mammary gland after delivery. It is 
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produced in low quantities in the first few days postpartum, is rich in immunologic 
components, such as secretory immunoglobulin (Ig)A, lactoferrin, leukocytes, and 
developmental factors, such as the epidermal growth factor (EGF) (Ballard and 
Morrow, 2013; Golinelli et al., 2014). Transitional milk is produced from 5 days to 2 
weeks postpartum, and meets the mounting nutritional requirements of the rapidly 
growing infant. Maturation increases in the next weeks, and by 4 to 6 weeks 
postpartum, human milk is considered fully mature (Ballard and Morrow, 2013). 
 
 
Results 
 
Several studies to determine the antioxidant potential in the different types of breast 
milk were conducted. These studies are usually designed so that the milk is harvested in 
different periods of breastfeeding, and then TAC is determined in the different portions 
collected.  
A resume of some of the research efforts aiming to determine TAC/TAS in human milk 
published in the last years are depicted in Table 1. 
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Table 1. Studies evaluating TAS/TAC (Total Antioxidant System/Total Antioxidant Capacity) in human milk and the main conclusions 
withdrawn. 
Sample  
characteristics 
Method 
employed 
Results 
for TAS/TAC 
Conclusion 
a. 30 healthy women with term (39 
weeks) and preterm (32 weeks) babies 
(15+15); milk collected at 3 days 
(colostrum), 8 days (transition milk) 
and 30 days (mature milk) 
TEAC 
(ABTS) 
Fulterm: colostrum: 12; 
transitional milk: 9; mature milk: 
7 mM; Preterm: colostrum: 10; 
transitional milk: 7; mature milk: 
7 mM (results taken from graph) 
TAC decreased during lactation time; the 
fullterm group had a higher TAS than the 
preterm group, for all the collecting periods 
b. 145 women with full term newborns; 
milk collected at: colostrum (2 days), 
transitional milk (7 days) and mature 
milk (at 30, 90 and 180 days post 
partum); maternal plasma at 90 days 
FRAP assay Colostrum: 589.8; transitional 
508.5; mature milk: 453.5, 479.3 
and 402.6  μmol/l  
Colostrum showed a higher antioxidant 
capacity than the transitional and mature 
milks. Positive correlation between the 
antioxidant content of breast milk and 
maternal plasma. 
c. 56 samples of breast milk collected 
from mothers of premature infants (33 
weeks), between 4 and 145 days after 
birth 
assay similar 
to FRAP  
Formula milk: 2671; Breast milk: 
3807 μmol/L 
TAC in breast milk was negatively correlated 
with the postnatal age and significantly higher 
than in formula milk. A reason appointed was 
that human milk has endogenous antioxidants, 
not presented in formula  
d. 31 samples of mature milk collected 
by electric breast pump, subjected to 2 
different pasteurization techniques: 
Holder pasteurization (63ºC for 30 min) 
high pasteurization (75ºC for 15 sec) 
Commercial 
kit PAO-
DELTACLO
N 
in fresh milk: aprox. 0.25 mM 
equiv uric acid 
 
There was a decrease in total antioxidant 
capacity in milk samples subjected to thermal 
processing versus fresh milk samples. High 
pasteurization offers superior preservation of 
TAC than Holder pasteurization 
e. Pool of 100 samples from a milk bank 
(mature milk) 
ORAC (with 
fluorescein as 
the probe) 
3.41 to 2.46 μmolTE/mL ORAC with fluorescein can be used to 
determine TAS in human milk 
f. 60 women, 1 mo. after birth; milk 
collected after 5 minutes of feeding start 
(hindmilk) 
ORAC (with 
fluorescein as 
the probe) 
3.41 μmolTE/mL TAC was correlated with α-tocopherol 
concentration 
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g. 115 samples of colostrum (2 days), 97 
samples of transition milk (7 days) and 
293 samples of mature milk at 3 times 
(30, 90 and 180 days); samples taken by 
manual expression of each breast at 
morning 
FRAP assay  Colostrum: 1061.6 μmolTE/L; 
Transitional milk: 915 μmolTE/L; 
Mature milk: 816; 862; 724 
μmolTE/L 
The level of TAC decreased from colostrum 
to mature milk. 
h. 102 lactating women (31 for the entire 
study time); 1,4,8,12,and 16 weeks; 
milk collected by breast pump/manual 
expression before and after each fed on 
the same day 
Commercial 
kit (Randox 
® assay) 
(TEAC) 
7 days: 0.497 
4 weeks: 0.399 
8 weeks: 0.423 
12 weeks: 0.401 
16 weeks: 0.375 
mmolTE/L 
TAS decreased throughout the lactation time; 
Significant correlations were found between 
TAS and Cu, 
Zn and Se 
i. 7 subjects; milk collected between 1 and 
5 days postpartum (colostrum), at several 
different times during the day 
TEAC 
(ABTS) 
Values for TE varied throughout 
the day, from aprox. 0.004 TE at 
0h to 0.014 TE at 21.00h  
(values taken from a graph) 
A variation was reported for TAC day vs. 
night; lowest TAC measured at 0h and highest 
at 21.00 h 
j. 20 women (10 term and 10 preterm 
deliveries) in the 3
rd
, 7
th
 and 30
th
 day 
postpartum and 20 women (10 term (40 
weeks) and 10 preterm (36 weeks) 
deliveries) 5 months postpartum; TAC 
evaluated at 0h, 48h and 1 week (kept at 
4 and -8 ºC) 
Phosphomoly
bdenium 
method 
In fresh milk:  
Fulterm: colostrum: 112.9; 
Transitional milk: 103.93; Mature 
milk: 101.82 
Preterm: colostrum: 104.6; 
Transitional milk: 98.47; Mature 
milk: 97.45 μg/dL 
Higher antioxidant levels measured in 
colostrum; no difference between term and 
preterm deliveries; TAC reduced with time, 
with refrigeration and freezing 
k. 30 postpartum women who declared 
smoking more than 5 cig./day during 
pregnancy and lactation; milk collected 
the 3
rd
 day (colostrum) and 30
th
-32
nd
 day 
(mature milk) by electric pump, 2 h after 
the 1
st
 morning feeding 
Commercial 
kit (Randox 
® assay) 
(TEAC) 
Non smokers: Colostrum: 4.15; 
Mature milk: 5.25; 
Smokers: Colostrum: 2.99; 
Mature milk: 4.66 (mmol/L) 
This study revealed inferior antioxidant 
properties of breast milk from smokers; 
determination of maternal 8-isoprostane (a 
biomarker for oxidative stress in urine and 
milk): correlated negatively with milk TAS 
for non-smokers but not for smokers.  
l. 49 postpartum women, milk collected Commercial Colostrum: 3.59;  The phase of lactation does not affect the 
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the 3
rd
 day (colostrum) and 30
th
-32
nd
 day 
(mature milk) by electric pump, 2 h after 
the 1
st
 morning feeding 
kit (Randox 
® assay) 
(TEAC) 
Mature milk: 4.92 (mmol/L) degree of lipid oxidative damage in human 
milk. 
m. 80 lactating women in exclusively 
breastfeeding for 90 days, were given a 
symbiotic for 30 days; milk collected by 
manual expression before the first 
feeding in the morning 
Commercial 
kit (Randox 
® assay) 
(TEAC) 
Supplemented group: 0.312 to 
0.255; Placebo group: 0.317 to 
0.255 mmol TE/L 
Symbiotic (probiotic and prebiotic) 
supplementation increased TAC levels  
n. 184 infants, divided in 2 groups: I 
(term-38.6 weeks) and II (preterm-33.7 
weeks); colostrum samples collected 
using a vacuum pump before infant 
feeding 
TEAC 
(ABTS) 
Group I: 2.62 
Group II: 2.41 
mmol TE/L 
In newborns (preterm and term) small for 
gestational age, an increase in plasmatic 
oxidative stress was observed; the differences 
found in TAS levels in breast milk were not 
significantly different 
o. 20 assymptomatic HIV-infected 
lactating women and and 30 
age‑matched HIV‑free lactating 
mothers, 15 days to 2 mo. post partum 
FRAP assay Infected: 850 μmol/L; 
Non-infected: 884 μmol/L; 
It could be concluded from this study that 
hypoalbuminemia is a feature of 
HIV‑infected lactating mothers and that their 
breast milk of has low antioxidant capacity. 
p. 60 samples from 15 women; milk 
collected at aprox. 7, 14, 21 and 28 days 
afer birth at the end of the morning 
feeding 
TEAC 
(ABTS) 
TAC decreased from aprox. 1.2 at 
7 days to 0.9 mmol TE/L at 28 
days 
TAC decreases significantly in the 1
st
 month 
of lactation and TAC in breast milk is mainly 
due to the presence of bioactive proteins 
q. 98 women with a single preterm (31 
weeks) infant; milk collected at day 4 
(colostrums) with a vacuum pump from 
one breast before the feedind and used 
fresh or stored at -80ºC for 3 mo 
TEAC 
(ABTS) 
Fresh milk: 3.2 mmol TE/L 
Stored milk: 3.8 mmol TE/L 
Storage at -80ºC does not change the 
antioxidant content of human milk 
a) Quiles et al., 2006; b) Zarban et al., 2007; c) Ezaki et al., 2008; d) Silvestre et al., 2008; e) Sáenz et a., 2009; f) Tijerina-Sáenz et al., 2009; g) 
Zarban et al., 2009; h) Matos et al., 2009; i) Cubero et al., 2009; j) Xavier et al., 2011; k) Zagierski et al., 2012; l) Szlagatys-Sidorkiewicz et al., 
2012; m) Nikniaz et al., 2013; n) Sandal et al., 2013; o) Rahamon et al., 2013; p) Mehta and Petrova, 2014; q) Akdag et al., 2014 
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Several research efforts have been conducted in order to determine whether the breast 
milk has a stronger antioxidant power when compared to formula milk. Aycicek and co-
workers (2006) studied the antioxidant effects of breast milk in 3 and 6 months old 
children, by measuring plasma TAC, total peroxide levels and oxidative stress index 
(percentage of total peroxide to TAC), and showed that plasma TAC was significantly 
higher (while total peroxide levels and oxidative stress index were significantly lower) 
in the breast-fed group, when compared to the formula-fed group (TAC: 2.3 vs 2.0 
mmol TE/L). Positive significant correlations were found between uric acid, albumin 
and total bilirrubin and plasma TAC in both groups, and a negative correlation between 
TAC and plasma iron. These results demonstrate that human milk provides better 
antioxidant power than formula. Similar results were obtained by Ledo et al., in 2009, 
by comparing 29 breastfed and 34 formula fed babies (using several urinary markers for 
oxidative stress) and concluding that breast milk has more powerful antioxidant effects 
on lowering the infant´s oxidative status. In 2010, Oveisi and colleagues measured total 
antioxidative activity by FRAP assay in 140 human breast milk samples and 80 infant 
formulas and showed that breast milk has a higher TAC level and provides better 
antioxidant power than formula. Later, Alpinar et al. (2012) studied 16 healthy breastfed 
infants and 18 formula fed, 3 to 6 months old, and reported a higher level of 
antioxidants in the plasma of the breastfed group. In a posterior study, Lugonja et al. 
(2013) performed an ex vivo study on the effect of human milk and formula on the 
contraction of the uterine rat muscle, and concluded that breast milk induced the 
relaxation of calcium-initiated muscle contractions, while the infant formulas did not 
have such an effect. Besides, a higher level of superoxide dismutase activity and a 
higher content of reducing agents were found in human milk. 
On the other hand, Korchazhkina et al. (2006) collected samples of milk from 20 
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mothers who had had premature babies and urine of the milk fed babies (10 breast-fed 
and 10 formula-fed, 4-6 days old) and reported the malondialdehyde levels (a marker of 
lipid peroxidation) in those samples. The conclusion withdrawn was that both breast 
milk and formula were sufficient to prevent lipid peroxidation in healthy preterm 
newborns. In a more recent study, Friel and co-workers (2011) studied 65 premature 
babies and did not find a correlation between ORAC results or lipid peroxidation and 
breastfed or formula fed children, and concluded that the differences in the antioxidant 
role of these two milk sources are subtle, and may take long to manifest. 
 
Discussion 
 
These studies have demonstrated that Total antioxidant status (TAS) is higher in 
colostrum, in harmony with a higher oxidative stress in the newborn caused by the 
delivery, and decrease throughout lactation period, as the baby ´s own defense system 
matures (Ezaki et al., 2008; Zarban et al., 2009; Matos et al, 2009).  
From the described studies, one can observe that the obtained results comparing formula 
and breast milk are dubious and diffident, and depend on the type of analysis conducted 
for determining TAS. Indeed, most adapted milks produced today are fortified with 
vitamins and other compounds with antioxidative activity, which leads to high 
antioxidant levels when chemical methods are used for its determination. However, the 
fact that a mixture is characterized chemically as having a strong redox activity, does 
not necessarily imply that it has the same behavior in a biological environment; on the 
other hand, human milk is produced to meet more completely the child's requirements. 
The oxidant challenge seems to be more evident in premature babies, more susceptible 
to the effects of oxidative stress, because its antioxidant defense mechanism is still 
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undeveloped, and have a higher incidence of oxidative increasing circumstances, such 
as hyperoxia, reperfusion or inflammation (Perrone et al., 2007; Mehta and Petrova, 
2014). As described above, breastfeeding preterm babies can have a positive impact in 
their development, and plays an important role in protecting the premature infant. The 
results that compare milk from mothers with premature and fullterm babies are also 
baffling; Quiles et al. (2006) described a higher TAS level in milk from mothers with 
fullterm babies, but posterior research works did not corroborate those findings (Xavier 
et al., 2011; Sandal et al., 2013). 
Other studies have focused on the effect of lifestyle of the mother on the antioxidant 
status of her milk. The scarce results published suggest that supplementation with non-
alcoholic beer (Codoner-Franch et al., 2013) or symbiotics (Nikniaz et al., 2013) may be 
beneficial, while smoking appears as clearly detrimental (Zagierski et al., 2012). 
 
Types of antioxidants in human milk 
 
Vitamins 
Vitamins A, E and C have strong antioxidative activity. Vitamins A and E were found 
to be more concentrated in colostrum as compared to mature milk. 
Vitamin A 
Vitamin A is a liposoluble compound with antioxidative action, acting against reactive 
oxygen species (ROS). Carotenoids are a group of molecules structurally similar to 
vitamine A, some of them being its dietary source (provitamin A), as β- and α-
carotenes. The antioxidative activity of vitamin A and carotenoids is conferred by the 
conjugated carbon-carbon double bonds in the hydrophobic chain, which can quench 
singlet oxygen, neutralize thiol radicals, and combine with and stabilize peroxyl 
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radicals, and in this way protect the cells against peroxidative damage (Palace et al, 
1999; Rutkowski and Grzegorczyk, 2012). In general, the longer the polyene chain, the 
greater the peroxyl radical stabilizing ability (Landete, 2013). Moreover, vitamin A 
apparently suppresses the activity of enzymes participating in propagation of 
peroxidation of lipids, as well as prevents oxidative disorders of protein glycosylation in 
cell membranes (Rutkowski and Grzegorczyk, 2012; Sommer and Vyas, 2012). 
Vitamin A has a limited transplacental transfer, so mammal newborns have low stores 
of this compound, relying on milk consumption to maintain a suitable amount (Debier 
and Larondelle, 2005). Colostrum has an important role in providing initial protection to 
the newborn against deficiency, and it usually contains higher vitamin A concentrations 
than mature milk. Macias and Schweigert (2001) reported a vitamin A concentrations of 
1.02 ± 0.56 lg ⁄mL in colostrum, which declined to 0.33 ± 0.14 lg ⁄mL in the first weeks 
of lactation. Nevertheless, according to Tijerina-Sáenz (2009), vitamin A concentration 
did not significantly contribute to milk antioxidant capacity at 1 month of breast-feeding 
and only a modest role of this compound was found in improving clinical outcomes and 
incidence of bronchopulmonary dysplasia (Mentro, 2004).  
The β-carotene and lutein are the most abundant carotenoids in human milk samples, 
and a sharp decrease in carotenoid content is also noted as a function of lactation stage 
(Song et al., 2013). β-carotene also quenches 1O2, and neutralizes various free radicals, 
deactivates the earlier formed peroxy radicals of the body’s lipids, preventing their 
propagation and participation in peroxidative processes (Rutkowski and Grzegorczyk, 
2012).As a result of the above mentioned reactions, the decrease in plasma β-carotene 
concentration in newborns may be implicated in oxidative stress related diseases 
(Vogelsang et al., 2009). 
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Vitamin E 
The terms α-tocopherol and vitamin E are often used alternatively; in fact, though 
vitamin E has eight forms (four tocopherols (α, β, γ, δ) and four tocotrienols (α, β, γ, δ),  
α-tocopherol constitutes 90% of all the forms and is described as having the strongest 
biological activity (Rutkowski and Grzegorczyk, 2012; Landete, 2013). 
Vitamin E deactivates ROS, including 
1
O2 (singlet oxygen), O2
•–
 (superoxide radical 
anion) and HO
•
 (hydroxyl radical) (Rutkowski and Grzegorczyk, 2012). This powerful 
antioxidative activity of α-tocopherol makes it the main fat-soluble vitamin responsible 
for protecting cell membranes against peroxidation. As a lipophilic compound, it 
accumulates in circulating lipoproteins, cell membranes, and fatty deposits, reacting 
with free radicals and molecular oxygen, protecting polyunsaturated fatty acids 
(PUFAs) and lipoproteins from peroxidation. Vitamin E inhibits lipid peroxidation 
primarily by trapping peroxyl radicals (LOO
•
) through the following reaction (Debier 
and Larondelle, 2005): 
LOO
•
 + α-tocopherol →  LOOH  + α-tocopherol•   (α -tocopheroxyl radical) 
The antioxidant function of vitamin E is located in the chromanol nucleus, where the 
phenolic hydroxyl group donates an H atom to quench lipid radicals, becoming an α- 
tocopheroxyl radical, which, contrary to fatty acids, is fairly stable, because the 
unpaired electron of the O atom is delocalized throughout the aromatic ring. α-
tocopherol can be regenerated from the tocopheroxyl radicals by cellular reductants, 
such as ascorbic acid (Debier and Larondelle, 2005).  
Vitamin E also regenerates the antioxidatively used up β-carotene and protects vitamin 
A against oxidation. Generally it plays such an important role in oxidative stress 
counteraction that it is considered to be the main lipophilic antioxidant of the body 
(Traber and Atkinson, 2007).  
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Vitamin E is extremely important from conception to postnatal development, but. 
during pregnancy placental transfer of vitamin E to the fetus is limited, making breast 
milk the only source of this nutrient for infants. Stimming et al. (2014) have determined 
α-tocopherol acetate, tocopherols, and tocotrienols from breast milk and infant formulas 
and showed that breast milk tends to contain higher ratios of vitamin E to unsaturated 
fatty acids than long chain polyunsaturated fatty acids (LC-PUFA) enriched formulas. 
Furthermore, higher concentrations of α-tocopherol were found in colostrum milk when 
compared to transitional and mature milk (Szlagatys-Sidorkiewicz et al., 2012), 
coincident with a significant reduction in the amount of some components of the fat 
globule, since most of the vitamin E is secreted as a constituent of the membrane of 
these globules (Lima et al., 2014). Still, vitamin E (and α-tocopherol in particular) 
seems to be highly accountable for the antioxidative capacity of breast milk at 1 month 
post-partum (Tijerina-Sáenz et al., 2009). Parity, anthropometric nutritional status, 
socioeconomic status, and habitual dietary intake of vitamin E by the mother do not 
appear to affect the levels of this nutrient in breast milk. Nevertheless, variables such as 
maternal age, α -tocopherol biochemical nutritional status, gestational age, and maternal 
vitamin E supplementation appear to have some degree of influence (Lima et al., 2014).  
 
Vitamin C 
Vitamin C (L- ascorbic acid) can act as an antioxidant since it has low reduction 
potential and can react with radicals and oxidants. The oxidation of ascorbate by one 
electron originates ascorbyl radical, that has a low reactivity due to resonance 
stabilization of the unpaired electron, and readily dismutates to ascorbate and 
dehydroascorbic acid (DHA) (Carr and Frei, 1999). The latter can regenerate back in 
ascorbate by enzyme-dependent pathways and nonenzymatically by glutathione and 
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lipoic acid. This reversible oxidation of ascorbate to DHA creates a redox system with 
the potential of 0.08 V, which allows it to act as an antioxidant. So, vitamin C has an 
important role in eliminating oxidative stress, being, due to its hydrosolubility, the main 
antioxidant of extracellular fluids. It plays an important role in breast milk antioxidative 
properties, and was associated with a reduced risk of atopy in high-risk infants (Hoppu 
et al., 2005). 
 
Proteins and enzymes 
The principal proteins in human milk are casein and whey protein. The β-casein is the 
predominant casein in human milk, which produces a lighter gastric curd with digestible 
floccules and reduces gastric emptying time. The major whey proteins are α-
lactalbumin, lactoferrin, immunoglobulin A (IgA), and serum albumin (Golinelli et al., 
2014). 
The protein content composition of human milk changes considerably during the course 
of lactation. Colostrum and transitional milk contain high concentrations of protein, but 
there is little casein, which increases with duration of milk production. During the first 
month of lactation, the protein content in human milk decreases to concentrations of 9–
11 g/L, and then decreases more slowly until the sixth month of breastfeeding. The 
concentration of whey proteins remains high during the whole lactation period (Stam et 
al., 2013). Several enzymes are also present in the human milk  
There are two sources of proteins in the milk: whey proteins are synthesized in the 
mammary gland, and other proteins such as serum albumin, various enzymes and 
protein hormones are transferred to milk from plasma; a dimer of the secretory IgA is 
synthesized by epithelial cells of the mammary gland from the connection of two IgA 
molecules produced locally by resident lymphocytes (Golinelli et al., 2014). 
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The mechanism of antioxidative activity of peptides and proteins is the result of the 
combination of three main actions: scavenging of free radicals, inhibition of lipid 
peroxidation and chelating of transition metal ions (Sarmadia and Ismail, 2010). 
Moreover, other antioxidant mechanisms were attributed to these compounds, such as 
reducing hydroperoxides, enzymatically eliminating specific oxidants, and altering the 
physical properties of food systems in a way that separates reactive species (Elias et al., 
2008). The induction of genes is another indirect mechanism by which peptides can 
keep cells safe from damage by ROS (Kruzel et al., 2013).  
Several studies suggest that the antioxidative activity of proteins and peptides is related 
to their amino acid composition: tyrosine (Tyr), tryptophan (Trp), methionine (Met), 
lysine (Lys), cysteine (Cys), phenylalanine (Phe) and histidine (His) are examples of 
amino acids that have antioxidative activity. Amino acids with aromatic residues 
structure (Tyr, Trp and Phe) can donate protons to electron deficient radicals, which 
improves their radical-scavenging properties. The antioxidative activity of His-
containing peptides is related to hydrogen-donating, lipid peroxyl radical trapping 
and/or the metal ion-chelating ability of the imidazole group, while the sulfhydryl (SH) 
group in cysteine has an independently crucial antioxidative action due to its direct 
interaction with radicals (by H donating). Hydrophobic residues (valine (Val), leucine 
(Leu) and Tyr improve the accessibility of proteins to hydrophobic radical species or 
polyunsaturated fatty acids (Elias et al., 2008; Sarmadia and Ismail, 2010; Power et al., 
2013). 
 
Lactoferrin 
Lactoferrin is a basic (pI 8.6) iron-binding protein that has antimicrobial and 
immunotrophic functions (Yen et al., 2011; Kruzel et al., 2013; Golinelli et al., 2014). It 
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consists of a single polypeptide chain that is folded in two highly homologous lobes, 
namely the N and C-lobe, with a Fe
3+
-binding site contained in each lobe (Sabatucci et 
al., 2007). This ability to bind iron is also the main mechanism of action of its 
antimicrobial activity, since ferric iron is essential for bacterial growth (Yen et al., 
2011); also, it appears that lactoferrin´s anti-inflammatory action depends on its ability 
to take up iron in the inflammation focus, where low pH inhibits iron retention by 
transferrin (Sokolov et al., 2009). Moreover, the high proportion of iron present in 
breast milk is bound to lactoferrin, which facilitates the mineral uptake by the intestinal 
cells, as this protein is relatively resistant to proteolytic degradation in the 
gastrointestinal tract when compared to other milk proteins, such as casein, hence 
facilitating the absorption of iron from milk by the neonate (Golinelli et al., 2014).  
This protein plays an important role in cellular redox modulation (Kruzel et al., 2013) 
and is found in high concentrations in the serum of human milk (Golinelli et al., 2014). 
Lactoferrin binds free iron, which initiates and catalyzes free-radical processes (as lipid 
peroxidation in biomembranes), since this metal enhances the Fenton reaction causing 
the production of the highly toxic hydroxyl radical (Belizi et al., 1999). Furthermore, 
lactoferrin forms a complex with ceruloplasmin, increasing its ferroxidase activity, 
being this complex found in breast milk, which is more evidence of the protective effect 
of these two proteins (Sabatucci et al., 2007; Sokolov et al., 2014). 
 
Glutathione peroxidase  
Selenium glutathione peroxidase is an enzyme that contains selenium as an essential 
component. It is a tetrameric protein composed of four apparently identical subunits, 
each containing one atom of selenium. Cellular glutathione peroxidase was the first 
enzyme recognized as a selenoprotein, the selenium component being present in the 
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form of selenocysteine. The plasma is identical but it is a glycosylated protein, and is 
kinetically, structurally and antigenically distinct from the cellular enzyme (Torres et 
al., 2003). Milk is another extracellular fluid known to contain glutathione peroxidase 
activity that confers protective effects against oxidative damage (L’Abbe and Friel, 
2000). This enzyme increases during lactation time (L’Abbe and Friel, 2000), although 
other studies have reported that its activity decreases (Torres et al., 2003). A reported 
positive association between glutathione peroxidase and long-chain polyunsaturated 
fatty acids in human milk can indicate that it may be involved in protecting milk lipids 
from oxidative stress by reducing fatty acid hydroperoxides (L’Abbe and Friel, 2000).  
Glutathione peroxidase catalyses the decomposition of hydrogen peroxide (H2O2) and 
organic hydroperoxides (L-OOH) using reduced glutathione (GSH), according to the 
following reaction (Torres et al., 2003; Elias et al., 2008): 
 
H2O2 + 2GSH → 2H2O + GSSG 
or 
LOOH + 2GSH → LOH + H2O + GSSG 
 
where GSSG is oxidized glutathione and LOH is a fatty acid alcohol. 
 
Superoxide dismutase (SOD) 
Mn- superoxide dismutase and Cu/Zn- superoxide dismutase have been identified in 
human milk, and both catalyze the conversion of superoxide anion to hydrogen peroxide 
by the following reaction (Elias et al. 2008; Tsukahara, 2013): 
2O2
−
    +     2H
+
   →   O2     +     H2O2 
The hydrogen peroxide thus formed, then suffers the action of the enzyme catalase. 
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The amount of Cu/Zn- superoxide dismutase decreases throughout the lactation (França 
et al., 2010), although a peak around the 3
rd
 week was described for both superoxide 
dismutases by some authors (L’Abbe and Friel, 2000; Kasapović et al., 2005).  
 
Catalase 
Catalase is a heme-containing enzyme found in many biological systems that catalyzes 
the conversion of hydrogen peroxide to water by the reaction (Elias et al. 2008): 
2 H2O2   →   2 H2O + O2 
Catalase was identified as the most important factor in bovine milk that maintains its 
oxidative stability (Silanikove et al., 2014). In human milk, its concentration decreases 
with lactation time (Friel et al., 2002). 
 
Ceruloplasmin 
Ceruloplasmin is a multi-functional copper containing protein that belongs to the family 
of multicopper oxidases and accounts for 95% of human plasma copper (Sabatucci et 
al., 2007; Samygina et al., 2013). Ceruloplasmin is described as having antioxidative 
properties due to a series of enzymatic properties, such as being a ferroxidase (inhibiting 
the formation of hydroxyl radicals in the Fenton reaction and ferrous stimulated lipid 
peroxidation) (Sokolov et al, 2014). These properties make ceruloplasmin an effective 
antioxidant, able to prevent oxidative damage to proteins, DNA and lipids (Atanasiu et 
al., 1998). Alternative mechanisms of antioxidative properties have been described, 
such as the decomposition of lipid peroxides or the scavenging of superoxide, hydroxyl 
and H2O2 radicals in a stoichiometric manner. It was described that ceruloplasmin was 
far more effective as a peroxyl radical scavenger than superoxide dismutase, but slightly 
less effective than catalase, and is an effective chain-breaking antioxidant for a variety 
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of radicals, independently of its catalytic ferroxidase activity (Atanasiu et al., 1998). As 
stated above, lactoferrin forms a complex with ceruloplasmin, which increases the 
ferroxidase activity of the latter (Sabatucci et al., 2007; Sokolov et al., 2014). 
 
Other proteins, peptides and aminoacids have also antioxidative properties and were 
described as human milk components. Thioredoxin is an ubiquitary multifunctional 
protein that has a redox active region within the sequence Cys-Gly-Pro-Cys, protecting 
against oxidative stress by scavenging ROS, as well as having an anti-inflammatory 
activity. Birth stimulates the release of thioredoxin by the neonates, and early human 
milk is a rich source of this protein that contributes to the redox balance (Todoroki et 
al., 2005). Published data suggest that 60% of the variability of breast milk TAC is 
accounted for by leptin, adiponectin, lactoferrin and lysozyme (Mehta and Petrova, 
2014). Mandal et al. (2014) have fractionated and purified several peptides from human 
milk and have identified two peptides has having antioxidative properties; lactoferricin 
(a fragment of lactoferrin), which appears to have also an excellent iron withholding 
capacity that accounts for inhibiting the oxidation of DPPH and ABTS radicals; the 
other antioxidant peptide identified was kappa casein, containing a short N-terminal 
containing repeated tyrosine, which may be the cause of preventing oxidation.  
Other highly potent antioxidant peptides can be generated by enzymatic hydrolysis 
(pepsin and pancreatin) of human milk proteins (Hernández-Ledesma et al., 2007; 
Tsopmo et al., 2009; Tsopmo et al., 2011). 
 
Other molecules 
Coenzyme Q10 
Coenzyme Q10 or ubiquinone is a lipossoluble vitamin-like 1, 4-benzoquinone that has a 
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very potent action as an antioxidant and a free radical scavenger. It is an essential 
component of oxidative phosphorylation at the mitochondrial level, where it helps to 
stabilize cell membranes. Coenzyme Q10 is acquired both by endogenous biosynthesis 
and from dietary intake (Quiles et al., 2006; Knuppel et al., 2012). Several studies have 
been conducted to determine coenzyme Q10 throughout the lactation (Niklowitz et al., 
2005; Quiles et al., 2006; Tang et al., 2006). Tang et al. (2006) have determined the 
concentration of ubiquinone in breast milk by HPLC and have reported a mean 
concentration 0.315 ± 0.205 μmol L−1 (ranging from 0.073 to 1.93 μmol L−1). Quiles 
et al. (2006) reported a concentration of 0.8 μmol/L for coenzyme Q10 in colostrum 
(HPLC), and a decrease with breastfeeing duration. Moreover, the concentration of this 
antioxidant molecule is lower in milk of preterm babies (for colostrum and transition 
milk, whilst equivalent for mature milk) and its concentration is directly correlated with 
the antioxidant capacity of the milk (Quiles et al., 2006). Higher increases in coenzyme 
Q10 blood levels have been observed in breast-fed infants when compared with formula-
fed infants during the first days of life, which is likely related to the exogenous supply 
from breast milk (Compagnoni et al, 2004). 
 
Melatonin 
Melatonin (N-acetyl-5-methoxytryptamine) is a serotonin derivative, sensitized 
endogenously in the pineal gland that acts highly effectively as an antioxidant and free 
radical scavenger. It interact with various free radicals in vitro and in vivo, stimulates 
the activity of several antioxidative enzymes (catalase, copper/zinc superoxide 
dismutase, glutathione peroxidase), down-regulates pro-oxidative enzymes 
(myloperoxidase, nitric oxide synthase) (Reiter et al., 2009), and has demonstrated a 
positive effect in a multitude of neonatal diseases (Gitto et al., 2013). Melatonin has 
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been quantified in human milk by several researchers (Kimata, 2007; Honorio-França et 
al., 2013; Karunanithi et al., 2014) and has proven as to have a positive effect in the 
neonate´s wellbeing (Engler et al., 2012). 
 
Trace elements and metals 
The antioxidant system may involve also trace elements, such as iron (Fe), copper (Cu), 
zinc (Zn), and selenium (Se), elements that exist in small concentrations but exhibit 
redox potentials that exert their antioxidant effects. Besides acting as redox catalysts, 
these trace elements, can form part of the active site or are cofactors of antioxidant 
enzymes, and play an important part on the newborn´s antioxidant defense in the early 
post-birth period. Fe is important for the catalase activity, Cu and Zn are cofactors in the 
expression of Cu/Zn superoxide-dismutase, and Se is an essential component of 
glutathione peroxidase (Oshiro et al., 2001). 
Matos and coworkers have studied 102 lactating women in a longitudinal study for 4 
months (only 31 women completed the study throughout the entire time) and reported 
the concentrations of Cu, Zn, Mn (manganese) and Se (determined by inductively 
coupled plasma-mass spectrometry) from 7 days to 4 months. The concentration of all 
these elements decreased with the progress of lactation, and a positive correlation with 
TAS were observed for all elements, except for Mn. In a recent study, the role of the 
trace elements (cobalt, vanadium, rubidium and tellurium) in the antioxidant system was 
also put in evidence (Matos et al., 2014). 
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Conclusion 
The antioxidant status of the offspring is highly dependent on the antioxidant status of 
the mother during pregnancy and, after birth, maintained by the synthesis of endogenous 
molecules by the newborn and infant and at the cost of exogenous molecules conveyed 
by the milk. The antioxidant capacity of human milk comprises endogenous and 
exogenous molecules, from vitamins (A, E, C), to enzymes (glutathione peroxidase, 
superoxide dismutase), metals (copper (Cu), zinc (Zn), and selenium (Se)) and other 
molecules (coenzyme Q10, melatonin) that can act in a synergistic manner to deactivate 
free radicals. Several studies have demonstrated that colostrum has the highest 
antioxidant potential, and that there is a reduction in total TAC during the course of 
lactation. The concentration of specific antioxidants also varies during the lactation: the 
activity of molecules such as vitamins and coenzyme Q10, or elements such as copper 
(Cu), zinc (Zn), and selenium (Se) decrease, while for other enzymes the concentration 
varies (for superoxide dismutase a peak in the 3
rd
 week was described and glutathione 
peroxidase´s concentration increases). Formula milk also has a strong antioxidative 
activity, with modern formulas being highly supplemented with reducing molecules, but 
several studies point that human milk has a stronger capacity to decrease oxidative 
biomarkers in the plasma of infants studied. 
A healthy diet and lifestyle during pregnancy seem to be crucial for an adequate Total 
Antioxiant Status (TAS), increasing with the mother´s supplementation with non-
alcoholic beer and symbiotic intake, and decreasing with smoking and infection.  
All these findings convey the certainty that human milk is important to decrease the 
oxidative stress that can lead to multiple dysfunctions, and that its composition in 
antioxidant molecules varies during lactation to proportionate the best care to the 
newborn.
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